Document Detail


Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
MedLine Citation:
PMID:  11477329     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) are used to treat depression. Whereas cardiovascular effects have occasionally been reported during controlled studies with SSRIs, TCA treatment poses a well-known problem in this respect. To investigate the putative correlation between antidepressant dose or serum levels and adverse effects, the authors devised a naturalistic study to evaluate the tricyclic antidepressants' and SSRIs' effect on the cardiovascular system. The authors also compared antidepressant serum levels to adverse effects. Inpatients treated with TCAs or SSRIs were included; an electrocardiogram (ECG) and a Schellong test were carried out on the day patients entered the hospital and during steady-state treatment with antidepressant drugs when blood was drawn for therapeutic drug monitoring. The patient population consisted of 114 acutely depressed patients; 81 patients were treated with TCAs and 33 with SSRIs. The TCAs comprised amitriptyline (n = 43), clomipramine (n = 11), doxepin (n = 19) and imipramine (n = 8); the SSRIs comprised fluvoxamine (n = 14) and paroxetine (n = 19). In TCA-treated patients, the authors observed the same type of abnormalities in conduction and orthostatic hypotension as had been observed earlier. The authors also observed cases of first-degree atrioventricular block, prolonged QTc interval, and orthostatic hypotension in SSRI-treated patients. Thus SSRIs also appear to affect the cardiovascular system, which might pose a problem for patients with preexisting conduction disease. The authors observed a strong correlation between the decrease in systolic pressure and antidepressant serum concentration (except for clomipramine and paroxetine), suggesting that antidepressant serum level is a better correlate than dose.
Authors:
B Rodriguez de la Torre; J Dreher; I Malevany; M Bagli; M Kolbinger; H Omran; B Lüderitz; M L Rao
Related Documents :
23433899 - The effect of drinking goals at treatment entry on longitudinal alcohol use patterns am...
15600379 - Long-term management of major depressive disorder: are differences among antidepressant...
16007589 - Prescribing practices of selective serotonin reuptake inhibitors (ssris) among pediatri...
12057029 - Influence of monoamine oxidase a and serotonin receptor 2a polymorphisms in ssri antide...
24018899 - The triangular association of adh1b genetic polymorphism, alcohol consumption and the r...
21784729 - Assessment by mri of inflammation and damage in rheumatoid arthritis patients with meth...
20227249 - Cortical thickness and voxel-based morphometry in depressed elderly.
8389689 - The relationship of mean daily blood alcohol levels to admission mast, clinic absenteei...
9586489 - Effect of increased maxillo-mandibular relationship on isometric strength in tmd patien...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Therapeutic drug monitoring     Volume:  23     ISSN:  0163-4356     ISO Abbreviation:  Ther Drug Monit     Publication Date:  2001 Aug 
Date Detail:
Created Date:  2001-07-30     Completed Date:  2001-10-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7909660     Medline TA:  Ther Drug Monit     Country:  United States    
Other Details:
Languages:  eng     Pagination:  435-40     Citation Subset:  IM    
Affiliation:
Departments of Psychiatry and Psychotherapy, University of Bonn, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Antidepressive Agents, Tricyclic / adverse effects,  blood*,  therapeutic use
Cardiovascular System / drug effects*
Depression / blood*,  drug therapy
Electrocardiography / drug effects*
Female
Humans
Hypotension, Orthostatic / chemically induced
Male
Middle Aged
Serotonin Uptake Inhibitors / adverse effects,  blood*,  therapeutic use
Chemical
Reg. No./Substance:
0/Antidepressive Agents, Tricyclic; 0/Serotonin Uptake Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of acetaldehyde in pregnancy outcome after prenatal alcohol exposure.
Next Document:  Fluorescence polarization immunoassay: can it result in an overestimation of vancomycin in patients ...